​

Zhengye Biotechnology Ownership | Who Owns Zhengye Biotechnology?

OverviewChart

Zhengye Biotechnology Ownership Summary

Zhengye Biotechnology is owned by 0.26% institutional investors, and 99.74% retail investors.

ZYBT Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockZhengye Biotechnology0.26%-99.74%
SectorHealthcare Stocks 35.49%11.75%52.76%
IndustrySpecialty & Generic Drug Manufacturers Stocks20.36%13.75%65.89%

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20268-20.00%121,043-47.44%-107.64%2-60.00%433.33%
Dec 31, 202510-230,30245.08%-431.02%5-16.67%3-
Sep 30, 20251025.00%158,743-62.25%-42.34%6-25.00%3-
Jun 30, 20258166.67%420,50831375.15%-11241125.00%8166.67%--
Mar 31, 20253-1,336---3---

Insider Transactions Trends

DateBuySell
2026 Q1--

ZYBT Ownership FAQ

Who Owns Zhengye Biotechnology?

Zhengye Biotechnology shareholders are primarily institutional investors at 0.26%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Zhengye Biotechnology's industry, Specialty & Generic Drug Manufacturers Stocks, is 20.36%, which Zhengye Biotechnology falls below.

Does Blackrock own Zhengye Biotechnology?

BlackRock is not among the top 10 institutional shareholders of Zhengye Biotechnology.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools